Breast Cancer Research Stamp Reauthorization Act of 2015
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
92pct
225d open
vs 3,548 other S bills in the 114th — cohort avg 43d
(This measure has not been amended since it was introduced. The expanded summary of the Senate reported version is repeated here.) Breast Cancer Research Stamp Reauthorization Act of 2015 (Sec. 2) This bill reauthorizes through December 31, 2019, provisions requiring the U.S. Postal Service to issue a special postage stamp for first-class mail that costs more than the regular first-class stamp to raise funds for breast cancer research. (Sec. 3) Agencies receiving these funds from the Postal Service must use them on breast cancer research.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (7)
Became Public Law No: 114-99.
Became Public Law No: 114-99.
Signed by President.
Signed by President.
Presented to President.
Presented to President.
On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 422 - 1 (Roll no. 648). (consideration: CR H8678-8679; text: CR 11/30/2015 H8433-8435)
HouseMotion to reconsider laid on the table Agreed to without objection.
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 422 - 1 (Roll no. 648).(consideration: CR H8678-8679; text: CR 11/30/2015 H8433-8435)
HouseAt the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2016 · fourth_quarter · Health Issues
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119 & S.2748, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; H.R.3381 & S.1883, Childhood Cancer STAR Act; and regulations relating to tanning beds. In addition, regulatory issues before the FDA relating to laboratory developed tests, and any legislation pertaining thereto, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, and H.R.644 - America Gives More Act, CDC opioid prescription guidelines, and legislation relating to opioid prescribing, addition and rehabilitation; H.R.5475, the Health Equity and Accountability Act; S.2787, the SAME Act and Senate Amendment 4369 to S.2943, the Senate Defense Authorization bill; and S.3136, H.R.5003 childhood nutrition bill; and H.R.2017 and S.2217, the Common Sense Nutrition Disclosure Act; and S.524 and H.R.953, the Comprehensive Addiction and Recovery Act, and related bills and amendments, S.3077, the Marijuana Effective Drug Studies Act of 2016.
Client expense: $1,640,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
2016 · fourth_quarter · Health Issues
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119 & S.2748, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; H.R.3381 & S.1883, Childhood Cancer STAR Act; and regulations relating to tanning beds. In addition, regulatory issues before the FDA relating to laboratory developed tests, and any legislation pertaining thereto, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, and H.R.644 - America Gives More Act, CDC opioid prescription guidelines, and legislation relating to opioid prescribing, addition and rehabilitation; H.R.5475, the Health Equity and Accountability Act; S.2787, the SAME Act and Senate Amendment 4369 to S.2943, the Senate Defense Authorization bill; and S.3136, H.R.5003 childhood nutrition bill; and H.R.2017 and S.2217, the Common Sense Nutrition Disclosure Act; and S.524 and H.R.953, the Comprehensive Addiction and Recovery Act, and related bills and amendments, S.3077, the Marijuana Effective Drug Studies Act of 2016.
Client expense: $1,620,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
2016 · fourth_quarter · Health Issues
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119 & S.2748, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; H.R.3381 & S.1883, Childhood Cancer STAR Act; and regulations relating to tanning beds. In addition, regulatory issues before the FDA relating to laboratory developed tests, and any legislation pertaining thereto, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, and H.R.644 - America Gives More Act, CDC opioid prescription guidelines, and legislation relating to opioid prescribing, addition and rehabilitation; H.R.5475, the Health Equity and Accountability Act; S.2787, the SAME Act and Senate Amendment 4369 to S.2943, the Senate Defense Authorization bill; and S.3136, H.R.5003 childhood nutrition bill; and H.R.2017 and S.2217, the Common Sense Nutrition Disclosure Act; and S.524 and H.R.953, the Comprehensive Addiction and Recovery Act, and related bills and amendments, S.3077, the Marijuana Effective Drug Studies Act of 2016.
Client expense: $1,630,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
2016 · third_quarter · Health Issues
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119 & S.2748, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; H.R.3381 & S.1883, Childhood Cancer STAR Act; and regulations relating to tanning beds. In addition, regulatory issues before the FDA relating to laboratory developed tests, and any legislation pertaining thereto, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, and H.R.644 - America Gives More Act, CDC opioid prescription guidelines, and legislation relating to opioid prescribing, addition and rehabilitation; H.R.5475, the Health Equity and Accountability Act; S.2787, the SAME Act and Senate Amendment 4369 to S.2943, the Senate Defense Authorization bill; and S.3136, H.R.5003 childhood nutrition bill; and H.R.2017 and S.2217, the Common Sense Nutrition Disclosure Act; and S.524 and H.R.953, the Comprehensive Addiction and Recovery Act, and related bills and amendments, S.3077, the Marijuana Effective Drug Studies Act of 2016.
Client expense: $1,200,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
2016 · second_quarter · Health Issues
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119 & S.2748, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; H.R.3381 & S.1883, Childhood Cancer STAR Act; and regulations relating to tanning beds. In addition, regulatory issues before the FDA relating to laboratory developed tests, and any legislation pertaining thereto, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, and H.R.644 - America Gives More Act, CDC opioid prescription guidelines, and legislation relating to opiod prescribing, addition and rehabilitation; H.R.5475, the Health Equity and Accountability Act; S.2787, the SAME Act and Senate Amendment 4369 to S.2943, the Senate Defense Authorization bill; and S.3136, H.R.5003 childhood nutrition bill; and H.R.2017 and S.2217, the Common Sense Nutrition Disclosure Act; and S.524 and H.R.953, the Comprehensive Addiction and Recovery Act, and related bills and amendments.
Client expense: $1,250,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
2016 · first_quarter · Health Issues
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; and regulations relating to tanning beds. In addition, regulatory issues before the F.D.A relating to laboratory developed tests, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, H.R.644 - America Gives More Act; and CDC opioid prescription guidelines.
Client expense: $760,000 · Firm income: Not reported
2016 · first_quarter · Health Issues
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; and regulations relating to tanning beds. In addition, regulatory issues before the F.D.A relating to laboratory developed tests, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, H.R.644 - America Gives More Act; and CDC opioid prescription guidelines.
Client expense: $760,000 · Firm income: Not reported
2016 · first_quarter · Health Issues
Health Insurance Coverage, Genetic Testing (general); Health Disparities (general); Emergency Contraception (general); Health Care Reform Implementation; Drug Dependence (general); HIV Screening (general); Gynecologic Cancer (general); Breast Cancer (general); Breastfeeding (general); Medical Liability Reform (general); Health IT (general); Prematurity (general); Disparities (general); Prevention and Public Health Fund (general); Maternal Mortality and Morbidity (general); Imaging (general); Graduate Medical Education (general); Quality Improvement Measurement (general); Contraception (general); Postpartum Depression (general); CMS Provider Penalties (general); Preeclampsia (general); National Health Service Corps (general); Abortion (general); Indian Health (general); Teaching Health Centers (general); Research in Pregnant and Breastfeeding Women (general); Meaningful Use Stage 3; H.R. 3940, Meaningful Use Hardship Relief Act; H.R.4695/S. 466, Quality Care for Moms and Babies Act; H.R. 3865/S.2542, Cradle Act; H.R. 836/S. 884, Health Care Safety Net Enhancement Act; H.R. 865, Good Samaritan Health Professionals Act; H.R. 2603/S. 1475, Saving Lives, Saving Costs Act; H.R. 4774, Training Tomorrows Doctors Today Act; H.R. 3658/S. 84, GEDI Act; H.R. 4771, Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2016; H.R. 1209/S.628 Improving Access to Maternity Care Act; Implementation of H.R. 1462/S. 799, Protecting our Infants Act; H.R. 3691/S. 2226, Improving Treatment for Pregnant and Postpartum Women Act; H.R. 448/S.217, Women's Health Protection Act of 2015; H.R. 2972, Equal Access to Abortion Coverage in Health Insurance (EACH Woman) Act; H.R. 3504/S. 1603, Born-Alive Abortion Survivors Protection Act; H.Res. 461, Establishing a Select Investigative Panel of the Committee on Energy and Commerce; Fetal Tissue Research (General); H.Res. 558/S.Res. 327, Condemning Violence That Targets Healthcare for Women; Senate Biomedical Innovations Packages (general); S. 2745, Advancing NIH Strategic Planning and Representation in Medical Research Act; S.2742, Promoting Biomedical Research and Public Health for Patients Act; H.R. 3656/S. 2100, Tobacco to 21 Act; H.R. 3652/S. 674, 21st Century Womens Health Act; S. 1532, Affordability is Access Act; H.R. 2191/S. 1170, Breast Cancer Research Stamp Reauthorization Act of 2015; H.R. 1925, To award a Congressional Gold Medal to Dr. Ernie Bodai; H.R. 2058, FDA Deeming Authority Clarification Act of 2015; H.R. 3441, Accurate Education for Prenatal Screenings Act; H.R. 3235/S. 2311, Bringing Postpartum Depression Out of the Shadows Act; Shackling During Pregnancy (general); and H.R. 3539, Reinvigorating Antibiotic and Diagnostic Innovation Act.
2015 · fourth_quarter · Health Issues
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; and regulations relating to tanning beds. In addition, regulatory issues before the F.D.A relating to laboratory developed tests, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, H.R.644 - America Gives More Act; and CDC opioid prescription guidelines.
Client expense: $1,960,000 · Firm income: Not reported
2015 · fourth_quarter · Health Issues
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; and regulations relating to tanning beds. In addition, regulatory issues before the F.D.A relating to laboratory developed tests, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, H.R.644 - America Gives More Act; and CDC opioid prescription guidelines.
Client expense: $1,960,000 · Firm income: Not reported
2015 · fourth_quarter · Health Issues
Pub. Law No. 111-148, Patient Protection and Affordable Care Act, matters related to the implementation of breast health education, research and clinical trials; S.1566/H.R.2722, Cancer Drug Coverage Parity Act, advocate to require insurance companies cover iv-administered and orally-administered anti-cancer drugs at the same cost to patients; H.R.1600, Patients' Access to Treatment Act, support amending the Public Health Service Act to establish cost-sharing limits for health plans that cover prescription drugs and use a formulary or other tiered cost-sharing structure and prohibits such a health plan from imposing higher cost-sharing requirements, including co-payment and co-insurance, for specialty drugs than for other prescription drugs in a non-preferred brand drug tier; H.R.1608, Lymphedema Treatment Act, support Medicare coverage of certain lymphedema compression treatment items as durable medical equipment; S.1170/H.R.2191, Breast Cancer Research Stamp Reauthorization Act, advocate for the reauthorization of the breast cancer research stamp; S.370/H.R.716, Breast Density and Mammography Reporting Act, issues related to the information provided to women and doctors on breast density and the potential impact it has on the detection of breast cancer and require the FDA to utilize up to date medical information and direct HHS to focus research on the best screening methods for breast tissue; H.R.1925, Dr. Balazs "Ernie" Bodai Congressional Gold Medal, support the presentation of a congressional gold medal to Dr. Balaz "Ernie" Bodai in recognition of his many outstanding contributions to the nation, including a tireless commitment to breast cancer research; S.1192/H.R.2540, Breast Cancer Patient Education Act, efforts to support creating an educational campaign to inform breast cancer patients anticipating surgery about the availability and coverage of breast reconstruction and prostheses; H.R.6, 21st Century Cures Act, issues related to cancer prevention and research funding; S.620/H.R.1189, Preserving Employee Wellness Programs Act, issues related to the Genetic Information Act of 2008 and workplace wellness programs; S.1926/H.R.3339, Protecting Access to Lifesaving Screenings Act, amends Title XVIII of the Social Security Act to protect coverage for screening mammography; H.R.2846, Planning Actively for Cancer Treatments Act, support coverage of cancer care planning and coordination services; S.91/H.R.4112, Mobile Mammography Promotion Act, issues related to excluding mobile mammography vehicles from the motor fuel excise tax; H.R.3119, Palliative Care and Hospice Education and Training Act, support federal funding for research, training, education and awareness into palliative care.
2015 · fourth_quarter · Medicare/Medicaid
H.R. 2 - Medicare Access and CHIP Reauthorization Act of 2015 H.R. 6 - 21st Century Cures H.R. 1190 - Protecting Seniors' Access to Medicare Act of 2015 S. 258/H.R. 169 - Critical Access Hospital Relief Act of 2015 H.R. 3796 (113th) - Comprehensive Care Payment Innovation Act H.R. 648/S. 763 - Trauma Systems and Regionalization of Emergency Care Reauthorization Act H.R. 1070 (113th) - Removing Barriers to Colorectal Cancer Screening Act of 2013 H.R. 33/S. 420 - Protecting Volunteer Firefighters and Emergency Responders Act/Standard of Care protection act H.R. 1462/S. 799 - Protecting Our Infants Act of 2015 H.R. 531 - Accelerating Biomedical Research Act H.R. 887 - Electronic Health Fairness Act of 2015 H.R. 865 - Good Samaritan health professionals act H.R. 1220 - Removing Barriers to Colorectal Cancer Screening Act of 2015 S. 289 - American Cures Act H.R. 2603 /S. 1475 - Savings Lives, Saving Costs Act S. 884/H.R. 836 - the Health Care Safety Net Enhancement Act H.R. 647 - the Access to Life-Saving Trauma Care for All Americans Act S. 1148 - the Resident Physician Shortage Reduction Act of 2015 H.R. 1707 - the Access to Frontline Health Care Act H.R. 1859 - Ensuring Childrens Access to Specialty Care Act H.R. 1934 - Cancer Care Payment Reform Act of 2015 H.R. 1936 - Improving the Integrity of Disability Evidence Act H.R. 1688 - To amend the Veterans Access, Choice, and Accountability Act of 2014 to designate 20 graduate medical education residency positions specifically for the study of optometry. H.R. 3309 - Flex-IT 2 Act H.R. 3024 - Disproportionate Share Hospital bill H. Res 487 - Recognizing the importance of cancer program accreditation in ensuring comprehensive, high quality, patient-centered cancer care HR 2846 - Planning Actively for Cancer Treatment (PACT) Act of 2015 HR 3119 - Palliative Care and Hospice Education and Training Act S. 1170 - Breast Cancer Research Stamp Reauthorization Act of 2015 GME Surgical Workforce Shortages/Issues ICD-10 HEALTH Act Response to Senate FDA report HPSA Surgical Incentive Program Cancer Program Accreditation IPAB Electronic Health Records Breast Cancer Research In-Office Ancillary Services Exception BETOS coding system Health Insurance Mergers Stark Law APMS Alternative Payment Models Meaningful Use Stage 3 Delay Firearm safety Primary Care Incentive Payment Merit-Based Incentive Payment System (MIPS) implementation Medicare Physician Fee Schedule Quality and Payment Issues General Surgery, Rural Surgery Bonuses Chronic Care Issues Qualified clinical data registry (QCDR) and Physician Quality Reporting System (PQRS)
2015 · fourth_quarter · Health Issues
H.R. 2 - Medicare Access and CHIP Reauthorization Act of 2015 H.R. 6 - 21st Century Cures H.R. 1190 - Protecting Seniors' Access to Medicare Act of 2015 S. 258/H.R. 169 - Critical Access Hospital Relief Act of 2015 H.R. 3796 (113th) - Comprehensive Care Payment Innovation Act H.R. 648/S. 763 - Trauma Systems and Regionalization of Emergency Care Reauthorization Act H.R. 1070 (113th) - Removing Barriers to Colorectal Cancer Screening Act of 2013 H.R. 33/S. 420 - Protecting Volunteer Firefighters and Emergency Responders Act/Standard of Care protection act H.R. 1462/S. 799 - Protecting Our Infants Act of 2015 H.R. 531 - Accelerating Biomedical Research Act H.R. 887 - Electronic Health Fairness Act of 2015 H.R. 865 - Good Samaritan health professionals act H.R. 1220 - Removing Barriers to Colorectal Cancer Screening Act of 2015 S. 289 - American Cures Act H.R. 2603 /S. 1475 - Savings Lives, Saving Costs Act S. 884/H.R. 836 - the Health Care Safety Net Enhancement Act H.R. 647 - the Access to Life-Saving Trauma Care for All Americans Act S. 1148 - the Resident Physician Shortage Reduction Act of 2015 H.R. 1707 - the Access to Frontline Health Care Act H.R. 1859 - Ensuring Childrens Access to Specialty Care Act H.R. 1934 - Cancer Care Payment Reform Act of 2015 H.R. 1936 - Improving the Integrity of Disability Evidence Act H.R. 1688 - To amend the Veterans Access, Choice, and Accountability Act of 2014 to designate 20 graduate medical education residency positions specifically for the study of optometry. H.R. 3309 - Flex-IT 2 Act H.R. 3024 - Disproportionate Share Hospital bill H. Res 487 - Recognizing the importance of cancer program accreditation in ensuring comprehensive, high quality, patient-centered cancer care HR 2846 - Planning Actively for Cancer Treatment (PACT) Act of 2015 HR 3119 - Palliative Care and Hospice Education and Training Act S. 1170 - Breast Cancer Research Stamp Reauthorization Act of 2015 GME Surgical Workforce Shortages/Issues ICD-10 HEALTH Act Response to Senate FDA report HPSA Surgical Incentive Program Cancer Program Accreditation IPAB Electronic Health Records Breast Cancer Research In-Office Ancillary Services Exception BETOS coding system Health Insurance Mergers Stark Law APMS Alternative Payment Models Meaningful Use Stage 3 Delay Firearm safety Primary Care Incentive Payment Merit-Based Incentive Payment System (MIPS) implementation Medicare Physician Fee Schedule Quality and Payment Issues General Surgery, Rural Surgery Bonuses Chronic Care Issues Qualified clinical data registry (QCDR) and Physician Quality Reporting System (PQRS)
2015 · fourth_quarter · Medicare/Medicaid
H.R. 2 - Medicare Access and CHIP Reauthorization Act of 2015 H.R. 6 - 21st Century Cures H.R. 1190 - Protecting Seniors' Access to Medicare Act of 2015 S. 258/H.R. 169 - Critical Access Hospital Relief Act of 2015 H.R. 3796 (113th) - Comprehensive Care Payment Innovation Act H.R. 648/S. 763 - Trauma Systems and Regionalization of Emergency Care Reauthorization Act H.R. 1070 (113th) - Removing Barriers to Colorectal Cancer Screening Act of 2013 H.R. 33/S. 420 - Protecting Volunteer Firefighters and Emergency Responders Act/Standard of Care protection act H.R. 1462/S. 799 - Protecting Our Infants Act of 2015 H.R. 531 - Accelerating Biomedical Research Act H.R. 887 - Electronic Health Fairness Act of 2015 H.R. 865 - Good Samaritan health professionals act H.R. 1220 - Removing Barriers to Colorectal Cancer Screening Act of 2015 S. 289 - American Cures Act H.R. 2603 /S. 1475 - Savings Lives, Saving Costs Act S. 884/H.R. 836 - the Health Care Safety Net Enhancement Act H.R. 647 - the Access to Life-Saving Trauma Care for All Americans Act S. 1148 - the Resident Physician Shortage Reduction Act of 2015 H.R. 1707 - the Access to Frontline Health Care Act H.R. 1859 - Ensuring Childrens Access to Specialty Care Act H.R. 1934 - Cancer Care Payment Reform Act of 2015 H.R. 1936 - Improving the Integrity of Disability Evidence Act H.R. 1688 - To amend the Veterans Access, Choice, and Accountability Act of 2014 to designate 20 graduate medical education residency positions specifically for the study of optometry. H.R. 3309 - Flex-IT 2 Act H.R. 3024 - Disproportionate Share Hospital bill H. Res 487 - Recognizing the importance of cancer program accreditation in ensuring comprehensive, high quality, patient-centered cancer care HR 2846 - Planning Actively for Cancer Treatment (PACT) Act of 2015 HR 3119 - Palliative Care and Hospice Education and Training Act S. 1170 - Breast Cancer Research Stamp Reauthorization Act of 2015 GME Surgical Workforce Shortages/Issues ICD-10 HEALTH Act Response to Senate FDA report HPSA Surgical Incentive Program Cancer Program Accreditation IPAB Electronic Health Records Breast Cancer Research In-Office Ancillary Services Exception BETOS coding system Health Insurance Mergers Stark Law APMS Alternative Payment Models Meaningful Use Stage 3 Delay Firearm safety Primary Care Incentive Payment Merit-Based Incentive Payment System (MIPS) implementation Medicare Physician Fee Schedule Quality and Payment Issues General Surgery, Rural Surgery Bonuses Chronic Care Issues Qualified clinical data registry (QCDR) and Physician Quality Reporting System (PQRS)
2015 · fourth_quarter · Health Issues
H.R. 2 - Medicare Access and CHIP Reauthorization Act of 2015 H.R. 6 - 21st Century Cures H.R. 1190 - Protecting Seniors' Access to Medicare Act of 2015 S. 258/H.R. 169 - Critical Access Hospital Relief Act of 2015 H.R. 3796 (113th) - Comprehensive Care Payment Innovation Act H.R. 648/S. 763 - Trauma Systems and Regionalization of Emergency Care Reauthorization Act H.R. 1070 (113th) - Removing Barriers to Colorectal Cancer Screening Act of 2013 H.R. 33/S. 420 - Protecting Volunteer Firefighters and Emergency Responders Act/Standard of Care protection act H.R. 1462/S. 799 - Protecting Our Infants Act of 2015 H.R. 531 - Accelerating Biomedical Research Act H.R. 887 - Electronic Health Fairness Act of 2015 H.R. 865 - Good Samaritan health professionals act H.R. 1220 - Removing Barriers to Colorectal Cancer Screening Act of 2015 S. 289 - American Cures Act H.R. 2603 /S. 1475 - Savings Lives, Saving Costs Act S. 884/H.R. 836 - the Health Care Safety Net Enhancement Act H.R. 647 - the Access to Life-Saving Trauma Care for All Americans Act S. 1148 - the Resident Physician Shortage Reduction Act of 2015 H.R. 1707 - the Access to Frontline Health Care Act H.R. 1859 - Ensuring Childrens Access to Specialty Care Act H.R. 1934 - Cancer Care Payment Reform Act of 2015 H.R. 1936 - Improving the Integrity of Disability Evidence Act H.R. 1688 - To amend the Veterans Access, Choice, and Accountability Act of 2014 to designate 20 graduate medical education residency positions specifically for the study of optometry. H.R. 3309 - Flex-IT 2 Act H.R. 3024 - Disproportionate Share Hospital bill H. Res 487 - Recognizing the importance of cancer program accreditation in ensuring comprehensive, high quality, patient-centered cancer care HR 2846 - Planning Actively for Cancer Treatment (PACT) Act of 2015 HR 3119 - Palliative Care and Hospice Education and Training Act S. 1170 - Breast Cancer Research Stamp Reauthorization Act of 2015 GME Surgical Workforce Shortages/Issues ICD-10 HEALTH Act Response to Senate FDA report HPSA Surgical Incentive Program Cancer Program Accreditation IPAB Electronic Health Records Breast Cancer Research In-Office Ancillary Services Exception BETOS coding system Health Insurance Mergers Stark Law APMS Alternative Payment Models Meaningful Use Stage 3 Delay Firearm safety Primary Care Incentive Payment Merit-Based Incentive Payment System (MIPS) implementation Medicare Physician Fee Schedule Quality and Payment Issues General Surgery, Rural Surgery Bonuses Chronic Care Issues Qualified clinical data registry (QCDR) and Physician Quality Reporting System (PQRS)
2015 · fourth_quarter · Health Issues
Health Insurance Coverage, Genetic Testing (general); Health Disparities (general); Emergency Contraception (general); Health Care Reform Implementation; Drug Dependence (general); HIV Screening (general); Gynecologic Cancer; Breast Cancer (general); Breastfeeding (general); Medical Liability Reform (general); Health IT (general); Prematurity (general); Disparities (general); Prevention and Public Health Fund (general); Maternal Mortality (general); Imaging (general); Graduate Medical Education (general); Quality Improvement Measurement (general); Contraception (general); Postpartum Depression (general); CMS Provider Penalties (general); Preeclampsia (general); National Health Service Corps (general); Abortion (general); Indian Health (general); Teaching Health Centers (general); Research in Pregnant and Breastfeeding Women (general); H.R. 2866, Healthy MOM Act; CMS Health IT Incentive Program, Meaningful Use Stage 3; H.R. 3940, Meaningful Use Hardship Relief Act; S. 466, Quality Care for Moms and Babies Act; S. 1427, Quality Measure Alignment Act of 2015; H.R. 836/S. 884, Health Care Safety Net Enhancement Act; H.R. 865, Good Samaritan Health Professionals Act; H.R. 2603/S. 1475, Saving Lives, Saving Costs Act; H.R. 3658/S. 84, GEDI Act; Pregnancy Discrimination (general); H.R. 2654/S. 1512, Pregnant Workers Fairness Act; H.R. 1209/S.628 Improving Access to Maternity Care Act; H.R. 1462/S.799, Protecting our Infants Act; H.R. 3691/S. 2226, Improving Treatment for Pregnant and Postpartum Women Act; H.R.36/S. 1553, Pain-Capable Unborn Child Protection Act; H.R. 448/S.217, Women's Health Protection Act of 2015; H.R. 3134/S. 764, Defund Planned Parenthood Act; H.R. 3504/S. 1603, Born-Alive Abortion Survivors Protection Act; H.R. 3495, Womens Public Health and Safety Act; H.Res. 461, Establishing a Select Investigative Panel of the Committee on Energy and Commerce; H.Res. 558/S.Res. 327, Condemning Violence That Targets Healthcare for Women; H.R. 6, 21st Century Cures Act; Innovation for Healthier Americans; H.R. 1375/S. 142, Child Nicotine Poisoning Prevention Act; H.R. 3656/S. 2100, Tobacco to 21 Act; H.R. 3652/S. 674, 21st Century Womens Health Act; S. 1532, Affordability is Access Act; H.R. 2191/S. 1170, Breast Cancer Research Stamp Reauthorization Act of 2015; H.R. 1925, To award a Congressional Gold Medal to Dr. Ernie Bodai; H.R. 2058, FDA Deeming Authority Clarification Act of 2015; H.R. 3441, Accurate Education for Prenatal Screenings Act; H.R. 3339/S. 1926, Protecting Access to Lifesaving Screenings Act; H.R. 3235, Bringing Postpartum Depression Out of the Shadows Act; Shackling During Pregnancy (general); and H.R. 3539, Reinvigorating Antibiotic and Diagnostic Innovation Act.
2015 · fourth_quarter · Health Issues
Breast Density and Mammography Reporting Act of 2015 (S. 370/H.R. 716); Breast Cancer Research Stamp Reauthorization Act introduction (H.R. 2191/S. 1170).
Client expense: Not reported · Firm income: $10,000
Government targets: SENATE
2015 · third_quarter · Law Enforcement/Crime/Criminal Justice
Support clemency for Andrew Brannan. Support S. 178. Support the Department of Justice's updated Guidance for Federal Law Enforcement Agencies Regarding the Use of Race, Ethnicity, Gender, National Origin, Religion, Sexual Orientation, or Gender Identity, but would like to see it strengthened further to include state and local law enforcement agencies and close loopholes regarding the Department of Homeland Security. Oppose mandatory minimum sentences Support restoring proportionality to drug sentencing. Support promotion and adequately fund recidivism reduction and reentry programming. Support making sentencing reductions retroactive. Support expanding the Bureau of Prison's Compassionate Release Program. Support expanding time credits for good behavior. Support the BOP's providing voter eligibility information to all upon release from prison or jail. Support continued federal funding of innocence and forensic science programs at the Department of Justice and the National Institute of Standards and Technology at the Department of Commerce in the final FY 2016 appropriations bill. Support S. 502/H.R. 920 Support H.R. 1232 Support a significant increase funding for federal programs that address domestic violence, sexual assault, dating violence and stalking Support H.R. 1255 Support H.R. 1253 / S. 467 Support S. 772 / H.R. 1459 Support requiring universal background checks on all gun sales Support a ban on military-style semi automatic assault guns Support a ban on high capacity ammunition clips Support tough new criminal penalties for straw purchasers and gun traffickers Support executive action to ensure that both federal agencies and federal contractors are leading the way to making employment opportunities available for qualified job-seekers who have an arrest or conviction in their past. Support S. 295 Support the President's Task Force on 21st Century Policing Oppose the federal death penalty support federal support for local law enforcement agencies to purchase video surveillance equipment such as body cameras, gun cameras, dashboard cameras, and taser cameras Support the establishment of independent, effective civilian review boards for all levels of law enforcement Support legislation to review racial disparities in decisions by prosecutors Support the creation of uniform use of force standards for law enforcement officials. Support aggressive, comprehensive reform of civil asset forfeiture laws. Oppose deferring any campus judicial proceedings regarding sexual assaults until completion of criminal adjudication (investigation and trial). Oppose H.R. 1927 Promote employment of body worn cameras by law enforcement officers which also promotes and protect civil rights and civil liberties. Support S. 1119 / H.R. 2330 Support S. 1133 / H.R.2087 Support initiation by DoJ of a Pattern and Practice investigation of the Baltimore City Police Support the inclusion of civil right and civil liberties protections in the deployment of video surveillance by law enforcement officers Support HR 2875 Support HR 1933 / S 1056 Support HR 1124 Support HR 2197/ S. 1170 Support HR 2944 Support DOJs investigations of police misconduct involving domestic violence and sexual assault survivors, but support the Department doing more to build on the work the Department has already done and should address the fact that women face discriminatory police practices. Support S. 1169 / HR 2728 Support S. 1513 Support H Res 262 Support HR 2302 Support H Res 295 Support the inclusion of funding for Juvenile Justice Programs through the Juvenile Justice and Delinquency Prevention Program (JJDPA) in the House Appropriations Bill for the Departments of Commerce, Justice, and Science and related Agencies for FY 2016 Support S. 255 / H.R. 540 Oppose a new five-year mandatory minimum sentence for illegal reentry. Support: $4 million for the Wrongful Conviction Review Program at the Department of Justice (DoJ), Bureau of Justice Assistance (the Wrongful Conviction Review Program is a part of the Capital Litigation Improvement Program); $4 million for the Kirk Bloodsworth Post-Conviction DNA Testing Program (the Bloodsworth Program) at the DoJ, National Institute of Justice (NIJ); $15 million for the Paul Coverdell Forensic Sciences Improvement Grant Program (the Coverdell Program) at the NIJ; $5 million total for the Department of Justice to support the National Commission on Forensic Science; research at the National Institute of Justice; and related forensic science standards setting activities at the National Institute of Standards and Technology (NIST); Continuation of FY 15 spending levels at NIST to support forensic science research and measurement science. Support S 2168 Support HR 1124 Support HR 3470 / S 2021
2015 · third_quarter · Health Issues
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including H.R.3119, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act, and regulations relating to tanning beds. In addition, regulatory issues before the F.D.A relating to laboratory developed tests, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, and H.R.644 - America Gives More Act; an issues before the CDC, including opioid prescription guidelines.
Client expense: $1,190,000 · Firm income: Not reported
2015 · third_quarter · Health Issues
Pub. Law No. 111-148, Patient Protection and Affordable Care Act, matters related to the implementation of breast health education, research and clinical trials; S.1566/H.R.2739, Cancer Drug Coverage Parity Act, advocate to require insurance companies cover iv-administered and orally-administered anti-cancer drugs at the same cost to patients; H.R.1600, Patients' Access to Treatment Act, support amending the Public Health Service Act to establish cost-sharing limits for health plans that cover prescription drugs and use a formulary or other tiered cost-sharing structure and prohibits such a health plan from imposing higher cost-sharing requirements, including co-payment and co-insurance, for specialty drugs than for other prescription drugs in a non-preferred brand drug tier; H.R.1608, Lymphedema Treatment Act, support Medicare coverage of certain lymphedema compression treatment items as durable medical equipment; S.1170/H.R.2191, Breast Cancer Research Stamp Reauthorization Act, advocate for the reauthorization of the breast cancer research stamp; S.370/H.R.716, Breast Density and Mammography Reporting Act, issues related to the information provided to women and doctors on breast density and the potential impact it has on the detection of breast cancer and require the FDA to utilize up to date medical information and direct HHS to focus research on the best screening methods for breast tissue; H.R.1925, Dr. Balazs "Ernie" Bodai Congressional Gold Medal, support the presentation of a congressional gold medal to Dr. Balaz "Ernie" Bodai in recognition of his many outstanding contributions to the nation, including a tireless commitment to breast cancer research; S.1192/H.R.2540, Breast Cancer Patient Education Act, efforts to support creating an educational campaign to inform breast cancer patients anticipating surgery about the availability and coverage of breast reconstruction and prostheses; H.R.6, 21st Century Cures Act, issues related to cancer prevention and research funding; S.620/H.R.1189, Preserving Employee Wellness Programs Act, issues related to the Genetic Information Act of 2008 and workplace wellness programs; S.1926/H.R.3339, Protecting Access to Lifesaving Screenings Act, amends Title XVIII of the Social Security Act to protect coverage for screening mammography.
2015 · third_quarter · Health Issues
Health Insurance Coverage, Genetic Testing (general); Health Disparities (general); Emergency Contraception (general); Health Care Reform Implementation; Drug Dependence (general); HIV Screening (general); Gynecological Cancer; Breast Cancer (general); Breastfeeding (general); Medical Liability Reform (general); Health IT (general); Prematurity (general); Disparities (general); Prevention and Public Health Fund (general); Maternal Mortality (general); Imaging (general); Graduate Medical Education (general); Quality Improvement Measurement (general); Contraception (general); Postpartum Depression (general); CMS Provider Penalties (general); Preeclampsia (general); National Health Service Corps (general); Abortion (general); Indian Health (general); Teaching Health Centers (general); Research in Pregnant and Breastfeeding Women (general); H.R. 2866, Healthy MOM Act; CMS Health IT Incentive Program, Meaningful Use Stage 3; H.R. 1974, HEAL for Immigrant Women and Families Act of 2015; S. 466, Quality Care for Moms and Babies Act; S. 1427, Quality Measure Alignment Act of 2015; H.R. 836/S. 884, Health Care Safety Net Enhancement Act; H.R. 3658/S. 84, GEDI Act; H.R. 2603/S. 1475, Saving Lives, Saving Costs Act; Pregnancy Discrimination (general); S. 821, BPA in Food Packaging Right to Know Act; H.R. 1209/S.628 Improving Access to Maternity Care Act; H.R. 1462/S.799, Protecting our Infants Act; H.R. 6, 21st Century Cures Act; Innovation for Healthier Americans; Health Equity and Accountability Act; H.R. 293 Exempt certain transfers of value from reporting requirements under Sunshine Act; H.R. 1375/S. 142, Child Nicotine Poisoning Prevention Act; H.R. 3652/S. 674, 21st Century Womens Health Act; H.R.7/S. 582, No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2015; H.R.36/S. 1553, Pain-Capable Unborn Child Protection Act; H.R. 448/S.217, Women's Health Protection Act of 2015; H.R. 865, Good Samaritan Health Professionals Act of 2015; H.R. 2654/S. 1512, Pregnant Workers Fairness Act; S. 1532, Affordability is Access Act; H.R. 2191/S. 1170, Breast Cancer Research Stamp Reauthorization Act of 2015; H.R. 1925, To award a Congressional Gold Medal to Dr. Ernie Bodai; H.R. 2058, FDA Deeming Authority Clarification Act of 2015; H.R. 3656/S. 2100, Tobacco to 21 Act; H.R. 3441, Accurate Education for Prenatal Screenings Act; H.R. 3339/S. 1926, Protecting Access to Lifesaving Screenings Act; H.R. 3235, Bringing Postpartum Depression Out of the Shadows Act; Shackling During Pregnancy (general); H.R. 3134/S. 764, Defund Planned Parenthood Act; H.R. 3504/S. 1603, Born-Alive Abortion Survivors Protection Act; H.R. 3495, Womens Public Health and Safety Act; H.R. 3539, Reinvigorating Antibiotic and Diagnostic Innovation; H.R. 3539, Reinvigorating Antibiotic and Diagnostic Innovation Act; H.R. 2407, School Milk Nutrition Act of 2015.
2015 · third_quarter · Health Issues
Breast Density and Mammography Reporting Act of 2015 (S. 370/H.R. 716); Breast Cancer Research Stamp Reauthorization Act introduction (H.R. 2191/S. 1170).
Client expense: Not reported · Firm income: $10,000
Government targets: SENATE
2015 · second_quarter · Health Issues
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including follow-on legislation to H.R.1666 & S.2800, the Patient Centered Quality Care for Life Act, and, H.R.1339 (IH) & S.641, the Palliative Care and Hospice Education and Training Act (113th Congress), H.R.716 & S.370, the Breast Density & Mammography Reporting Act, and regulations relating to tanning beds. In addition, regulatory issues before the F.D.A relating to laboratory developed tests, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, and H.R.644 - America Gives More Act.
Client expense: $1,310,000 · Firm income: Not reported
2015 · second_quarter · Health Issues
Pub. Law No. 111-148, Patient Protection and Affordable Care Act, matters related to the implementation of breast health education, research and clinical trials; S.1695/H.R.3020, Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations Act, issues related to cancer prevention and research funding; S.1558/H.R.2685, Department of Defense Appropriations Act, issues related to cancer prevention and research funding; S.1566/H.R.2739, Cancer Drug Coverage Parity Act, advocate to require insurance companies cover iv-administered and orally-administered anti-cancer drugs at the same cost to patients; H.R.1600, Patients' Access to Treatment Act, support amending the Public Health Service Act to establish cost-sharing limits for health plans that cover prescription drugs and use a formulary or other tiered cost-sharing structure and prohibits such a health plan from imposing higher cost-sharing requirements, including co-payment and co-insurance, for specialty drugs than for other prescription drugs in a non-preferred brand drug tier; H.R.1608, Lymphedema Treatment Act, support Medicare coverage of certain lymphedema compression treatment items as durable medical equipment; S.1170/H.R.2191, Breast Cancer Research Stamp Reauthorization Act, advocate for the reauthorization of the breast cancer research stamp; H.R.2722, Breast Cancer Awareness Commemorative Coin Act, support the creation of a breast cancer awareness coin to increase the funding available for breast cancer research; S.370/H.R.716, Breast Density and Mammography Reporting Act, issues related to the information provided to women and doctors on breast density and the potential impact it has on the detection of breast cancer and require the FDA to utilize up to date medical information and direct HHS to focus research on the best screening methods for breast tissue; H.R.1925, Dr. Balazs "Ernie" Bodai Congressional Gold Medal, support the presentation of a congressional gold medal to Dr. Balaz "Ernie" Bodai in recognition of his many outstanding contributions to the nation, including a tireless commitment to breast cancer research; S.1192/H.R.2540, Breast Cancer Patient Education Act, efforts to support creating an educational campaign to inform breast cancer patients anticipating surgery about the availability and coverage of breast reconstruction and prostheses.
DEBATE - The House proceeded with forty minutes of debate on S. 1170.
Considered under suspension of the rules. (consideration: CR H8433-8435)
Mr. Chaffetz moved to suspend the rules and pass the bill.
Referred to the Subcommittee on Military Personnel.
Referred to the Subcommittee on Health.
Referred to the Committee on Oversight and Government Reform, and in addition to the Committees on Energy and Commerce, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Congress.gov source codes: H11100, H11100-A
Message on Senate action sent to the House.
Received in the House.
Passed Senate without amendment by Unanimous Consent. (consideration: CR S6906-6907; text as passed Senate: CR S6907)
Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.(consideration: CR S6906-6907; text as passed Senate: CR S6907)
Placed on Senate Legislative Calendar under General Orders. Calendar No. 233.
Committee on Homeland Security and Governmental Affairs. Reported by Senator Johnson without amendment. With written report No. 114-144.
Committee on Homeland Security and Governmental Affairs. Ordered to be reported without amendment favorably.
Read twice and referred to the Committee on Homeland Security and Governmental Affairs. (Sponsor introductory remarks on measure: CR S2578)
Introduced in Senate
| Senate |
| Reported by |
| September 17, 2015 |
| Homeland Security and Governmental Affairs Committee | Senate | Markup by | July 29, 2015 |
| Homeland Security and Governmental Affairs Committee | Senate | Referred to | April 30, 2015 |
| September 17, 2015 |
| Introduced in Senate | April 30, 2015 |
| Enrolled Bill | -- |
| Democratic |
| NY |
| Christopher A. Coons | Democratic | DE |
| Chuck Grassley | Republican | IA |
| Debbie Stabenow | Democratic | MI |
| Harry Reid | Democratic | NV |
| Heidi Heitkamp | Democratic | ND |
| Jeanne Shaheen | Democratic | NH |
| John Barrasso | Republican | WY |
| Jon Tester | Democratic | MT |
| Kelly Ayotte | Republican | NH |
| Lindsey Graham | Republican | SC |
| Mazie K. Hirono | Democratic | HI |
| Michael B. Enzi | Republican | WY |
| Orrin G. Hatch | Republican | UT |
| Patrick J. Toomey | Republican | PA |
| Richard J. Durbin | Democratic | IL |
| Robert Menendez | Democratic | NJ |
| Robert P. Casey, Jr. | Democratic | PA |
| Roy Blunt | Republican | MO |
| Sherrod Brown | Democratic | OH |
| Tammy Baldwin | Democratic | WI |
| Thad Cochran | Republican | MS |
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Client expense: $487,965 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, White House Office
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Client expense: $50,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Natl Institutes of Health (NIH), SENATE
Client expense: $20,300 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE, Veterans Affairs, Dept of (VA)
Client expense: $20,300 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE, Veterans Affairs, Dept of (VA)
Client expense: $96,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE, Veterans Affairs, Dept of (VA)
Client expense: $96,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE, Veterans Affairs, Dept of (VA)
Client expense: $333,697 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, White House Office
Client expense: $68,750 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Bureau of Alcohol Tobacco Firearms & Explosives, Bureau of Prisons (BOP), Bureau of the Census, Centers For Medicare and Medicaid Services (CMS), Consumer Financial Protection Bureau (CFPB), Council of Economic Advisers (CEA), Defense, Dept of (DOD), Education, Dept of, Election Assistance Commission (EAC), Environmental Protection Agency (EPA), Federal Communications Commission (FCC), Federal Deposit Insurance Corporation (FDIC), Federal Housing Finance Agency (FHFA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Interior, Dept of (DOI), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Credit Union Administration (NCUA), Natl Institute of Standards & Technology (NIST), Natl Telecommunications & Information Administration (NTIA), Office of Faith-Based & Community Initiatives, Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Client expense: $40,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Client expense: $498,494 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, White House Office
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Client expense: $80,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE